Iterum Therapeutics (ITRM) Proxy Filing summary

Executive summary

• Extraordinary general meeting scheduled for February 18, 2026, with four proposals up for shareholder vote.

• Board of directors and major proxy advisory firms unanimously recommend voting in favor of all proposals.

• Voting is encouraged online or by phone, with a deadline of February 17, 2026, at 11:59 PM ET for remote participation.

Voting matters and shareholder proposals

• Four proposals are on the agenda, as detailed in the definitive proxy statement filed January 2, 2026.

• Shareholders are urged to vote regardless of the number of shares owned.

• Institutional Shareholder Services and Glass Lewis both recommend voting for all proposals.

Board of directors and corporate governance

• Board of directors has unanimously recommended approval of all proposals.

• Communication to shareholders signed by the President and CEO.